Singapore markets closed
Straits Times Index
3,306.02 +6.02 (+0.18%) Nikkei
38,596.47 -36.55 (-0.09%) Hang Seng
18,028.52 -306.80 (-1.67%) FTSE 100
8,237.72 -34.74 (-0.42%) Bitcoin USD
64,266.16 -823.93 (-1.27%) CMC Crypto 200
1,329.52 -30.80 (-2.26%)
Adaptimmune Therapeutics plc (ADAP)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 223.05M |
| Enterprise value | 103.09M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 10.47 |
| Price/book (mrq) | 9.15 |
| Enterprise value/revenue | 5.62 |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 2.33 |
| 52-week change 3 | -8.11% |
| S&P500 52-week change 3 | 25.87% |
| 52-week high 3 | 2.0500 |
| 52-week low 3 | 0.4200 |
| 50-day moving average 3 | 1.0801 |
| 200-day moving average 3 | 0.9377 |
Share statistics
| Avg vol (3-month) 3 | 1.52M |
| Avg vol (10-day) 3 | 1.51M |
| Shares outstanding 5 | 255.56M |
| Implied shares outstanding 6 | 226.17M |
| Float 8 | 1.02B |
| % held by insiders 1 | 0.39% |
| % held by institutions 1 | 64.20% |
| Shares short (15 May 2024) 4 | 3.44M |
| Short ratio (15 May 2024) 4 | 3.3 |
| Short % of float (15 May 2024) 4 | 2.02% |
| Short % of shares outstanding (15 May 2024) 4 | 1.35% |
| Shares short (prior month 15 Apr 2024) 4 | 3.41M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 30 Mar 2018 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -867.58% |
Management effectiveness
| Return on assets (ttm) | -44.57% |
| Return on equity (ttm) | -301.91% |
Income statement
| Revenue (ttm) | 18.36M |
| Revenue per share (ttm) | 0.08 |
| Quarterly revenue growth (yoy) | -88.10% |
| Gross profit (ttm) | N/A |
| EBITDA | -183.91M |
| Net income avi to common (ttm) | -163.41M |
| Diluted EPS (ttm) | -0.7300 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 143.65M |
| Total cash per share (mrq) | 0.09 |
| Total debt (mrq) | 23.69M |
| Total debt/equity (mrq) | 97.20% |
| Current ratio (mrq) | 2.81 |
| Book value per share (mrq) | 0.09 |
Cash flow statement
| Operating cash flow (ttm) | -135.55M |
| Levered free cash flow (ttm) | -95.08M |
© 2024 Yahoo. All rights reserved.